A detailed history of Newman Dignan & Sheerar, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Newman Dignan & Sheerar, Inc. holds 19,481 shares of PFE stock, worth $577,806. This represents 0.14% of its overall portfolio holdings.

Number of Shares
19,481
Previous 20,211 3.61%
Holding current value
$577,806
Previous $560,000 2.68%
% of portfolio
0.14%
Previous 0.15%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

SELL
$25.26 - $29.6 $18,439 - $21,608
-730 Reduced 3.61%
19,481 $545,000
Q1 2024

Apr 26, 2024

SELL
$25.89 - $29.73 $86,394 - $99,209
-3,337 Reduced 14.17%
20,211 $560,000
Q4 2023

Feb 08, 2024

SELL
$26.13 - $33.94 $203,239 - $263,985
-7,778 Reduced 24.83%
23,548 $677,000
Q3 2023

Nov 07, 2023

SELL
$32.09 - $37.51 $45,439 - $53,114
-1,416 Reduced 4.32%
31,326 $1.04 Million
Q2 2023

Aug 02, 2023

BUY
$36.12 - $41.79 $325 - $376
9 Added 0.03%
32,742 $1.2 Million
Q1 2023

Apr 28, 2023

SELL
$39.39 - $51.28 $3,584 - $4,666
-91 Reduced 0.28%
32,733 $1.34 Million
Q4 2022

Jan 20, 2023

SELL
$41.75 - $54.5 $28,891 - $37,714
-692 Reduced 2.06%
32,824 $0
Q3 2022

Oct 18, 2022

BUY
$43.76 - $53.42 $11,858 - $14,476
271 Added 0.82%
33,516 $1.47 Million
Q2 2022

Aug 03, 2022

SELL
$46.53 - $55.17 $13,261 - $15,723
-285 Reduced 0.85%
33,245 $1.74 Million
Q1 2022

Apr 14, 2022

SELL
$45.75 - $56.69 $11,254 - $13,945
-246 Reduced 0.73%
33,530 $1.74 Million
Q4 2021

Jan 18, 2022

BUY
$41.32 - $61.25 $123 - $183
3 Added 0.01%
33,776 $1.99 Million
Q3 2021

Oct 07, 2021

SELL
$39.25 - $50.42 $5,848 - $7,512
-149 Reduced 0.44%
33,773 $1.45 Million
Q2 2021

Jul 28, 2021

BUY
$35.91 - $40.68 $118,395 - $134,121
3,297 Added 10.77%
33,922 $1.33 Million
Q1 2021

May 05, 2021

SELL
$33.49 - $37.77 $67,884 - $76,559
-2,027 Reduced 6.21%
30,625 $1.11 Million
Q4 2020

Jan 29, 2021

BUY
$33.47 - $42.56 $267 - $340
8 Added 0.02%
32,652 $1.2 Million
Q3 2020

Oct 14, 2020

BUY
$31.75 - $37.25 $15,875 - $18,625
500 Added 1.56%
32,644 $1.2 Million
Q2 2020

Aug 06, 2020

BUY
$30.12 - $36.54 $53,041 - $64,346
1,761 Added 5.8%
32,144 $1.25 Million
Q1 2020

Apr 20, 2020

SELL
$27.03 - $38.62 $20,056 - $28,656
-742 Reduced 2.38%
30,383 $1.09 Million
Q4 2019

Jan 15, 2020

BUY
$32.92 - $37.36 $34,566 - $39,228
1,050 Added 3.49%
31,125 $1.22 Million
Q3 2019

Oct 21, 2019

SELL
$32.49 - $42.13 $380,295 - $493,131
-11,705 Reduced 28.02%
30,075 $1.08 Million
Q2 2019

Jul 31, 2019

SELL
$36.98 - $41.52 $24,998 - $28,067
-676 Reduced 1.59%
41,780 $1.81 Million
Q1 2019

Apr 09, 2019

SELL
$37.5 - $41.2 $6,900 - $7,580
-184 Reduced 0.43%
42,456 $1.8 Million
Q4 2018

Jan 24, 2019

BUY
$38.47 - $43.86 $21,927 - $25,000
570 Added 1.35%
42,640 $1.86 Million
Q3 2018

Oct 25, 2018

BUY
$34.47 - $41.81 $4,170 - $5,059
121 Added 0.29%
42,070 $1.89 Million
Q2 2018

Jul 06, 2018

SELL
$32.98 - $35.16 $30,572 - $32,593
-927 Reduced 2.16%
41,949 $1.52 Million
Q1 2018

Apr 17, 2018

SELL
$31.91 - $37.02 $82,519 - $95,733
-2,586 Reduced 5.69%
42,876 $1.56 Million
Q4 2017

Jan 29, 2018

BUY
$33.26 - $35.29 $12,805 - $13,586
385 Added 0.85%
45,462 $1.65 Million
Q3 2017

Oct 18, 2017

BUY
$31.0 - $34.15 $434 - $478
14 Added 0.03%
45,077 $1.61 Million
Q2 2017

Aug 08, 2017

BUY
N/A
45,063
45,063 $1.51 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Newman Dignan & Sheerar, Inc. Portfolio

Follow Newman Dignan & Sheerar, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newman Dignan & Sheerar, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newman Dignan & Sheerar, Inc. with notifications on news.